[144] MaxLinear, Inc. SEC Filing

Rhea-AI Filing Summary

MaxLinear, Inc. (MXL) filed a Form 144 notifying a proposed sale of 102,157 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,765,108.49. The filing lists approximately 87,080,498 shares outstanding and an approximate sale date of 08/26/2025. The securities to be sold were acquired in three grants: 1,277 shares via an Employee Stock Purchase Plan on 05/17/2021, 47,725 restricted shares on 02/22/2019, and 53,155 performance shares on 02/17/2021. No sales by the seller were reported in the past three months. The signer certifies they have no undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of the number of shares and acquisition types (ESPP, restricted, performance) supporting compliance
• Brokered sale through Morgan Stanley Smith Barney suggests an orderly transaction rather than distressed selling
• No sales in past three months indicates the filer has not been actively disposing of large holdings recently

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 102,157 shares valued at $1.77M; appears procedural, not an earnings or operational signal.

This Form 144 reports a proposed sale by a person holding shares acquired from an ESPP, restricted stock, and performance shares. The sale size represents about 0.12% of the reported outstanding shares (102,157 of 87,080,498). The use of a major brokerage and the absence of recent sales suggest a planned, orderly disposition rather than urgent liquidation. There is no disclosure of material nonpublic information; the filer makes the standard certification.

Corporate Governance Expert

TL;DR: Governance process followed: required disclosure filed and seller attests to no undisclosed material information.

The Form 144 provides the required regulatory notice for selling restricted and performance-based equity. Acquisition dates and grant types are disclosed, which supports transparency around insider liquidity. The filing notes no sales in the prior three months, aligning with controlled selling practices. This is a routine compliance filing rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	102157	1765108.49	87080498	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/17/2021	Employee Stock Purchase Plan	Issuer			1277	05/17/2021	Cash
Common	02/22/2019	Restricted Stock	issuer			47725	02/22/2019	Not Applicable
Common	02/17/2021	Performance Shares	issuer			53155	02/17/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MaxLinear's (MXL) Form 144 report?

The filing reports a proposed sale of 102,157 common shares with an aggregate market value of $1,765,108.49 to be sold through Morgan Stanley Smith Barney.

When is the proposed sale date listed on the Form 144 for MXL?

The Form 144 shows an approximate sale date of 08/26/2025.

How were the shares being sold by the MXL filer originally acquired?

They were acquired via an Employee Stock Purchase Plan (1,277 shares on 05/17/2021), restricted stock (47,725 shares on 02/22/2019), and performance shares (53,155 shares on 02/17/2021).

Does the Form 144 indicate recent sales by the filer in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What certification does the seller provide in the Form 144?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.